DO | |||||||||
---|---|---|---|---|---|---|---|---|---|
#1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | #9 | |
Number of samples included,† n | 312 | 358 | 376 | 363 | 366 | 372 | 270 | 192 | 237 |
Number of villages included,† n | 9 | 10 | 11 | 10 | 13 | 13 | 10 | 6 | 8 |
Number of devices included,† n | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 3 |
Hb concentration (g/L), mean±SD | 121.5±12.9 | 124.0±12.9 | 121.2±13.0 | 124.5±12.9 | 123.6±13.8 | 121.1±14.5 | 119.0±11.6 | 118.0±12.8 | 122.3±15.7 |
*Total n=2846 women and n=9 HemoCue DOs.
†Number of total samples measured (out of total 2846), number of villages covered (out of total 26) and HemoCue devices used (out of total 12) by each DO.
‡Significant variability was observed in mean Hb concentrations across DOs (p<0.05, analysis of variance).
Hb, haemoglobin.